REFERENCES
1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48.
2. Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541-50.
3. Chen S, Zhu G, Yang Y, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23:87-98.
4. Yu W, Wang C, Shang Z, Tian J. Unveiling novel insights in prostate cancer through single-cell RNA sequencing. Front Oncol. 2023;13:1224913.
5. Zhong S, Zhang S, Fan X, et al. A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex. Nature. 2018;555:524-8.
6. Peng YL, Xiong LB, Zhou ZH, et al. Single-cell transcriptomics reveals a low CD8+ T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma. J Immunother Cancer. 2022;10:e004206.
7. Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP. Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach. Cell Rep Med. 2023;4:101199.
8. Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19:A68-77.
9. Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets - update. Nucleic Acids Res. 2013;41:D991-5.
10. Mortensen MM, Høyer S, Lynnerup AS, et al. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci Rep. 2015;5:16018.
11. Ross-Adams H, Lamb AD, Dunning MJ, et al; CamCaP Study Group. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study. EBioMedicine. 2015;2:1133-44.
12. Jain S, Lyons CA, Walker SM, et al. Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Ann Oncol. 2018;29:215-22.
13. He MX, Cuoco MS, Crowdis J, et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat Med. 2021;27:426-33.
14. Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.
15. Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773-82.
16. Kassambara A, Mundt F. factoextra: extract and visualize the results of multivariate data analyses. 2017. Available from: https://rpkgs.datanovia.com/factoextra/. [Last accessed on 23 Jun 2025].
18. Kassambara A. ggpubr: ‘ggplot2’ Based Publication Ready Plots. 2020. Available from: https://rpkgs.datanovia.com/ggpubr/. [Last accessed on 23 Jun 2025].
19. Wei T, Simko V, Levy M, et al. Package ‘corrplot’. Statistician of a correlation matrix. Available from: https://github.com/taiyun/corrplot. [Last accessed on 23 Jun 2025].
20. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
21. Kolde R. pheatmap: Pretty heatmaps. Version 1.0.13. 2025. Available from: https://cran.r-project.org/web/packages/pheatmap/index.html. [Last accessed on 23 Jun 2025].
22. Zhang X, Shi M, Chen T, Zhang B. Characterization of the immune cell infiltration landscape in head and neck squamous cell carcinoma to aid immunotherapy. Mol Ther Nucleic Acids. 2020;22:298-309.
23. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
24. Zhang Q, Ma Y, Yan Y, Zhang L, Zhang Y. CYB5R1 is a potential biomarker that correlates with stemness and drug resistance in gastric cancer. Transl Oncol. 2024;39:101766.
25. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-9.
26. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27-30.
27. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284-7.
28. Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.
29. Therneau TM, Lumley T. Package ‘survival’. R Top Doc. Available from: https://github.com/therneau/survival. [Last accessed on 23 Jun 2025].
30. Friedman J, Hastie T, Tibshirani R, et al. Lasso and elastic-net regularized generalized linear models. Available from: https://glmnet.stanford.edu/. [Last accessed on 23 Jun 2025].
31. Kassambara A, Kosinski M, Biecek P. survminer: Survival analysis and visualization. Available from: https://rpkgs.datanovia.com/survminer/index.html. [Last accessed on 23 Jun 2025].
32. Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32:5381-97.
33. Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747-56.
34. Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-87.e29.
35. Abdi H, Williams LJ. Principal component analysis. Wiley Interdiscip Rev Comput Stat. 2010;2:433-59.
36. Mcinnes L, Healy J, Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv 2018; arXiv:1802.03426. Available from: https://doi.org/10.48550/arXiv.1802.03426. [accessed 23 Jun 2025].
37. van der Maaten L, Hinton G. Visualizing high-dimensional data using t-SNE. J Mach Learn Res 2008;9:2579-605. Available from: https://www.jmlr.org/papers/volume9/vandermaaten08a/vandermaaten08a.pdf?fbcl. [Last accessed on 23 Jun 2025].
38. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-50.
39. Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22:bbab260.
40. Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41:D955-61.
41. Zhao R, Wang Y, Zhang M, et al. Screening of potential therapy targets for prostate cancer using integrated analysis of two gene expression profiles. Oncol Lett. 2017;14:5361-9.
42. Shalapour S, Font-Burgada J, Di Caro G, et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015;521:94-8.
43. Woo JR, Liss MA, Muldong MT, et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J Transl Med. 2014;12:30.
44. Wang B, Zhou Y, Zhang J, Jin X, Wu H, Huang H. Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity. Theranostics. 2020;10:1033-45.
45. Ke ZB, You Q, Chen JY, et al. A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients. Comput Biol Med. 2022;146:105711.
46. Wang H. MUC5B regulates alterations in the immune microenvironment in nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway. Discov Oncol. 2025;16:27.
47. Juric V, Mayes E, Binnewies M, et al. TREM1 activation of myeloid cells promotes antitumor immunity. Sci Transl Med. 2023;15:eadd9990.
48. Feng D, Li L, Shi X, et al. Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients. Aging. 2023;15:9358-76.
49. Huang X, Shi D, Zou X, et al. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate. Theranostics. 2023;13:339-54.
50. Tong D. Unravelling the molecular mechanisms of prostate cancer evolution from genotype to phenotype. Crit Rev Oncol Hematol. 2021;163:103370.
